Squamous cell carcinoma of the anal canal.

Hdl Handle:
http://hdl.handle.net/10147/203209
Title:
Squamous cell carcinoma of the anal canal.
Authors:
Martin, F T; Kavanagh, D; Waldron, R
Affiliation:
Department of Colorectal Surgery, Mayo General Hospital, Castlebar, Co. Mayo,, Ireland. fiachra1978@yahoo.com
Citation:
Surgeon. 2009 Aug;7(4):232-7.
Journal:
The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
Issue Date:
31-Jan-2012
URI:
http://hdl.handle.net/10147/203209
PubMed ID:
19736891
Abstract:
Squamous cell carcinoma ofthe anal canal represents 1.5% of all malignancies affectingthe gastrointestinal tract. Over the past 20 years dramatic changes have been seen in both the epidemiological distribution of the disease and in the therapeutic modalities utilised to manage it. CLINICAL MANAGEMENT: Historically abdominoperineal resection had been the treatment of choice with local resection reserved for early stage disease. Work by Nigro et al. has revolutionised how we currently manage carcinoma of the anal canal, demonstrating combined modality chemoradiotherapy as an appropriate alternative to surgical resection with the benefit of preserving sphincter function. Surgery is then reserved for recurrent disease with salvage abdominoperineal resection. This article reviews current literature and highlights the changing therapeutic modalities with selected clinical cases
Language:
eng
MeSH:
Adult; Aged; Anus Neoplasms/*diagnosis/*therapy; Carcinoma, Squamous Cell/*diagnosis/*therapy; Female; Humans; Male; Middle Aged
ISSN:
1479-666X (Print); 1479-666X (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorMartin, F Ten_GB
dc.contributor.authorKavanagh, Den_GB
dc.contributor.authorWaldron, Ren_GB
dc.date.accessioned2012-01-31T15:55:12Z-
dc.date.available2012-01-31T15:55:12Z-
dc.date.issued2012-01-31T15:55:12Z-
dc.identifier.citationSurgeon. 2009 Aug;7(4):232-7.en_GB
dc.identifier.issn1479-666X (Print)en_GB
dc.identifier.issn1479-666X (Linking)en_GB
dc.identifier.pmid19736891en_GB
dc.identifier.urihttp://hdl.handle.net/10147/203209-
dc.description.abstractSquamous cell carcinoma ofthe anal canal represents 1.5% of all malignancies affectingthe gastrointestinal tract. Over the past 20 years dramatic changes have been seen in both the epidemiological distribution of the disease and in the therapeutic modalities utilised to manage it. CLINICAL MANAGEMENT: Historically abdominoperineal resection had been the treatment of choice with local resection reserved for early stage disease. Work by Nigro et al. has revolutionised how we currently manage carcinoma of the anal canal, demonstrating combined modality chemoradiotherapy as an appropriate alternative to surgical resection with the benefit of preserving sphincter function. Surgery is then reserved for recurrent disease with salvage abdominoperineal resection. This article reviews current literature and highlights the changing therapeutic modalities with selected clinical casesen_GB
dc.language.isoengen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAgeden_GB
dc.subject.meshAnus Neoplasms/*diagnosis/*therapyen_GB
dc.subject.meshCarcinoma, Squamous Cell/*diagnosis/*therapyen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.titleSquamous cell carcinoma of the anal canal.en_GB
dc.contributor.departmentDepartment of Colorectal Surgery, Mayo General Hospital, Castlebar, Co. Mayo,, Ireland. fiachra1978@yahoo.comen_GB
dc.identifier.journalThe surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Irelanden_GB
dc.description.provinceConnacht-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.